nodes	percent_of_prediction	percent_of_DWPC	metapath
Guaifenesin—Nephrolithiasis—Ixabepilone—breast cancer	0.0397	0.0426	CcSEcCtD
Guaifenesin—Headache—Fluoxymesterone—breast cancer	0.0133	0.0143	CcSEcCtD
Guaifenesin—Carvedilol—HIF1A—breast cancer	0.013	0.187	CrCbGaD
Guaifenesin—Nausea—Fluoxymesterone—breast cancer	0.0126	0.0136	CcSEcCtD
Guaifenesin—Discomfort—Anastrozole—breast cancer	0.011	0.0119	CcSEcCtD
Guaifenesin—Discomfort—Letrozole—breast cancer	0.011	0.0119	CcSEcCtD
Guaifenesin—Urticaria—Fulvestrant—breast cancer	0.011	0.0119	CcSEcCtD
Guaifenesin—Vomiting—Lapatinib—breast cancer	0.0096	0.0103	CcSEcCtD
Guaifenesin—Urticaria—Exemestane—breast cancer	0.00958	0.0103	CcSEcCtD
Guaifenesin—Rash—Lapatinib—breast cancer	0.00952	0.0102	CcSEcCtD
Guaifenesin—Dermatitis—Lapatinib—breast cancer	0.00951	0.0102	CcSEcCtD
Guaifenesin—Headache—Lapatinib—breast cancer	0.00946	0.0102	CcSEcCtD
Guaifenesin—Dizziness—Fulvestrant—breast cancer	0.00918	0.00987	CcSEcCtD
Guaifenesin—Dizziness—Toremifene—breast cancer	0.00906	0.00974	CcSEcCtD
Guaifenesin—Nausea—Lapatinib—breast cancer	0.00897	0.00964	CcSEcCtD
Guaifenesin—Vomiting—Fulvestrant—breast cancer	0.00883	0.00949	CcSEcCtD
Guaifenesin—Rash—Fulvestrant—breast cancer	0.00875	0.00941	CcSEcCtD
Guaifenesin—Dermatitis—Fulvestrant—breast cancer	0.00875	0.0094	CcSEcCtD
Guaifenesin—Vomiting—Toremifene—breast cancer	0.00871	0.00937	CcSEcCtD
Guaifenesin—Headache—Fulvestrant—breast cancer	0.0087	0.00935	CcSEcCtD
Guaifenesin—Rash—Toremifene—breast cancer	0.00864	0.00929	CcSEcCtD
Guaifenesin—Dermatitis—Toremifene—breast cancer	0.00863	0.00928	CcSEcCtD
Guaifenesin—Headache—Toremifene—breast cancer	0.00858	0.00923	CcSEcCtD
Guaifenesin—Urticaria—Anastrozole—breast cancer	0.00851	0.00915	CcSEcCtD
Guaifenesin—Urticaria—Letrozole—breast cancer	0.00851	0.00915	CcSEcCtD
Guaifenesin—Nausea—Fulvestrant—breast cancer	0.00825	0.00886	CcSEcCtD
Guaifenesin—Nausea—Toremifene—breast cancer	0.00814	0.00875	CcSEcCtD
Guaifenesin—Urticaria—Idarubicin—breast cancer	0.00808	0.00868	CcSEcCtD
Guaifenesin—Dizziness—Exemestane—breast cancer	0.00797	0.00857	CcSEcCtD
Guaifenesin—Discomfort—Vinblastine—breast cancer	0.00778	0.00836	CcSEcCtD
Guaifenesin—Vomiting—Exemestane—breast cancer	0.00767	0.00824	CcSEcCtD
Guaifenesin—Rash—Exemestane—breast cancer	0.0076	0.00817	CcSEcCtD
Guaifenesin—Dermatitis—Exemestane—breast cancer	0.0076	0.00817	CcSEcCtD
Guaifenesin—Discomfort—Tamoxifen—breast cancer	0.00756	0.00812	CcSEcCtD
Guaifenesin—Headache—Exemestane—breast cancer	0.00755	0.00812	CcSEcCtD
Guaifenesin—Dizziness—Ixabepilone—breast cancer	0.00752	0.00809	CcSEcCtD
Guaifenesin—Vomiting—Ixabepilone—breast cancer	0.00723	0.00778	CcSEcCtD
Guaifenesin—Discomfort—Goserelin—breast cancer	0.00722	0.00776	CcSEcCtD
Guaifenesin—Rash—Ixabepilone—breast cancer	0.00717	0.00771	CcSEcCtD
Guaifenesin—Dermatitis—Ixabepilone—breast cancer	0.00717	0.00771	CcSEcCtD
Guaifenesin—Nausea—Exemestane—breast cancer	0.00716	0.0077	CcSEcCtD
Guaifenesin—Headache—Ixabepilone—breast cancer	0.00713	0.00766	CcSEcCtD
Guaifenesin—Dizziness—Anastrozole—breast cancer	0.00709	0.00762	CcSEcCtD
Guaifenesin—Dizziness—Letrozole—breast cancer	0.00709	0.00762	CcSEcCtD
Guaifenesin—Vomiting—Anastrozole—breast cancer	0.00681	0.00732	CcSEcCtD
Guaifenesin—Vomiting—Letrozole—breast cancer	0.00681	0.00732	CcSEcCtD
Guaifenesin—Nausea—Ixabepilone—breast cancer	0.00676	0.00727	CcSEcCtD
Guaifenesin—Rash—Anastrozole—breast cancer	0.00676	0.00726	CcSEcCtD
Guaifenesin—Rash—Letrozole—breast cancer	0.00676	0.00726	CcSEcCtD
Guaifenesin—Dermatitis—Letrozole—breast cancer	0.00675	0.00726	CcSEcCtD
Guaifenesin—Dermatitis—Anastrozole—breast cancer	0.00675	0.00726	CcSEcCtD
Guaifenesin—Dizziness—Raloxifene—breast cancer	0.00672	0.00723	CcSEcCtD
Guaifenesin—Headache—Anastrozole—breast cancer	0.00671	0.00722	CcSEcCtD
Guaifenesin—Headache—Letrozole—breast cancer	0.00671	0.00722	CcSEcCtD
Guaifenesin—Chlorphenesin—CYP19A1—breast cancer	0.00666	0.0956	CrCbGaD
Guaifenesin—Chlorphenesin—BCHE—breast cancer	0.00665	0.0954	CrCbGaD
Guaifenesin—Urticaria—Chlorambucil—breast cancer	0.00654	0.00703	CcSEcCtD
Guaifenesin—Vomiting—Raloxifene—breast cancer	0.00647	0.00695	CcSEcCtD
Guaifenesin—Vomiting—Idarubicin—breast cancer	0.00647	0.00695	CcSEcCtD
Guaifenesin—Discomfort—Vinorelbine—breast cancer	0.00646	0.00695	CcSEcCtD
Guaifenesin—Rash—Raloxifene—breast cancer	0.00641	0.00689	CcSEcCtD
Guaifenesin—Rash—Idarubicin—breast cancer	0.00641	0.00689	CcSEcCtD
Guaifenesin—Dermatitis—Idarubicin—breast cancer	0.00641	0.00689	CcSEcCtD
Guaifenesin—Dermatitis—Raloxifene—breast cancer	0.00641	0.00689	CcSEcCtD
Guaifenesin—Headache—Raloxifene—breast cancer	0.00637	0.00685	CcSEcCtD
Guaifenesin—Headache—Idarubicin—breast cancer	0.00637	0.00685	CcSEcCtD
Guaifenesin—Nausea—Anastrozole—breast cancer	0.00636	0.00684	CcSEcCtD
Guaifenesin—Nausea—Letrozole—breast cancer	0.00636	0.00684	CcSEcCtD
Guaifenesin—Nausea—Idarubicin—breast cancer	0.00604	0.00649	CcSEcCtD
Guaifenesin—Nausea—Raloxifene—breast cancer	0.00604	0.00649	CcSEcCtD
Guaifenesin—Urticaria—Tamoxifen—breast cancer	0.00583	0.00626	CcSEcCtD
Guaifenesin—Urticaria—Melphalan—breast cancer	0.0057	0.00613	CcSEcCtD
Guaifenesin—Urticaria—Goserelin—breast cancer	0.00556	0.00598	CcSEcCtD
Guaifenesin—Discomfort—Mitoxantrone—breast cancer	0.00533	0.00573	CcSEcCtD
Guaifenesin—Discomfort—Irinotecan—breast cancer	0.00533	0.00573	CcSEcCtD
Guaifenesin—Carvedilol—VEGFA—breast cancer	0.00525	0.0753	CrCbGaD
Guaifenesin—Vomiting—Chlorambucil—breast cancer	0.00524	0.00563	CcSEcCtD
Guaifenesin—Discomfort—Gemcitabine—breast cancer	0.00519	0.00558	CcSEcCtD
Guaifenesin—Discomfort—Fluorouracil—breast cancer	0.00511	0.00549	CcSEcCtD
Guaifenesin—Dizziness—Vinblastine—breast cancer	0.00499	0.00537	CcSEcCtD
Guaifenesin—Urticaria—Vinorelbine—breast cancer	0.00498	0.00536	CcSEcCtD
Guaifenesin—Nausea—Chlorambucil—breast cancer	0.00489	0.00526	CcSEcCtD
Guaifenesin—Dizziness—Tamoxifen—breast cancer	0.00485	0.00521	CcSEcCtD
Guaifenesin—Vomiting—Vinblastine—breast cancer	0.0048	0.00516	CcSEcCtD
Guaifenesin—Urticaria—Thiotepa—breast cancer	0.00476	0.00512	CcSEcCtD
Guaifenesin—Headache—Vinblastine—breast cancer	0.00473	0.00508	CcSEcCtD
Guaifenesin—Vomiting—Tamoxifen—breast cancer	0.00466	0.00501	CcSEcCtD
Guaifenesin—Dizziness—Goserelin—breast cancer	0.00463	0.00498	CcSEcCtD
Guaifenesin—Rash—Tamoxifen—breast cancer	0.00462	0.00497	CcSEcCtD
Guaifenesin—Dermatitis—Tamoxifen—breast cancer	0.00462	0.00497	CcSEcCtD
Guaifenesin—Headache—Tamoxifen—breast cancer	0.00459	0.00494	CcSEcCtD
Guaifenesin—Vomiting—Melphalan—breast cancer	0.00456	0.00491	CcSEcCtD
Guaifenesin—Rash—Melphalan—breast cancer	0.00453	0.00487	CcSEcCtD
Guaifenesin—Dermatitis—Melphalan—breast cancer	0.00452	0.00486	CcSEcCtD
Guaifenesin—Nausea—Vinblastine—breast cancer	0.00448	0.00482	CcSEcCtD
Guaifenesin—Vomiting—Goserelin—breast cancer	0.00445	0.00479	CcSEcCtD
Guaifenesin—Rash—Goserelin—breast cancer	0.00442	0.00475	CcSEcCtD
Guaifenesin—Dermatitis—Goserelin—breast cancer	0.00441	0.00474	CcSEcCtD
Guaifenesin—Headache—Goserelin—breast cancer	0.00439	0.00472	CcSEcCtD
Guaifenesin—Nausea—Tamoxifen—breast cancer	0.00436	0.00468	CcSEcCtD
Guaifenesin—Discomfort—Paclitaxel—breast cancer	0.00435	0.00467	CcSEcCtD
Guaifenesin—Nausea—Melphalan—breast cancer	0.00426	0.00458	CcSEcCtD
Guaifenesin—Nausea—Goserelin—breast cancer	0.00416	0.00447	CcSEcCtD
Guaifenesin—Dizziness—Vinorelbine—breast cancer	0.00415	0.00446	CcSEcCtD
Guaifenesin—Urticaria—Mitoxantrone—breast cancer	0.00411	0.00442	CcSEcCtD
Guaifenesin—Vomiting—Vinorelbine—breast cancer	0.00399	0.00429	CcSEcCtD
Guaifenesin—Dizziness—Thiotepa—breast cancer	0.00396	0.00426	CcSEcCtD
Guaifenesin—Rash—Vinorelbine—breast cancer	0.00395	0.00425	CcSEcCtD
Guaifenesin—Dermatitis—Vinorelbine—breast cancer	0.00395	0.00425	CcSEcCtD
Guaifenesin—Urticaria—Fluorouracil—breast cancer	0.00394	0.00423	CcSEcCtD
Guaifenesin—Headache—Vinorelbine—breast cancer	0.00393	0.00422	CcSEcCtD
Guaifenesin—Ranolazine—CYP2D6—breast cancer	0.00382	0.0549	CrCbGaD
Guaifenesin—Vomiting—Thiotepa—breast cancer	0.00381	0.00409	CcSEcCtD
Guaifenesin—Rash—Thiotepa—breast cancer	0.00378	0.00406	CcSEcCtD
Guaifenesin—Dermatitis—Thiotepa—breast cancer	0.00377	0.00406	CcSEcCtD
Guaifenesin—Headache—Thiotepa—breast cancer	0.00375	0.00403	CcSEcCtD
Guaifenesin—Nausea—Vinorelbine—breast cancer	0.00373	0.00401	CcSEcCtD
Guaifenesin—Discomfort—Capecitabine—breast cancer	0.00357	0.00384	CcSEcCtD
Guaifenesin—Nausea—Thiotepa—breast cancer	0.00356	0.00382	CcSEcCtD
Guaifenesin—Dizziness—Irinotecan—breast cancer	0.00342	0.00368	CcSEcCtD
Guaifenesin—Urticaria—Paclitaxel—breast cancer	0.00335	0.0036	CcSEcCtD
Guaifenesin—Oxprenolol—CYP2D6—breast cancer	0.00334	0.048	CrCbGaD
Guaifenesin—Vomiting—Irinotecan—breast cancer	0.00329	0.00354	CcSEcCtD
Guaifenesin—Vomiting—Mitoxantrone—breast cancer	0.00329	0.00354	CcSEcCtD
Guaifenesin—Ranolazine—CYP3A4—breast cancer	0.00328	0.0471	CrCbGaD
Guaifenesin—Dizziness—Fluorouracil—breast cancer	0.00328	0.00352	CcSEcCtD
Guaifenesin—Rash—Irinotecan—breast cancer	0.00326	0.00351	CcSEcCtD
Guaifenesin—Rash—Mitoxantrone—breast cancer	0.00326	0.00351	CcSEcCtD
Guaifenesin—Dermatitis—Irinotecan—breast cancer	0.00326	0.0035	CcSEcCtD
Guaifenesin—Dermatitis—Mitoxantrone—breast cancer	0.00326	0.0035	CcSEcCtD
Guaifenesin—Headache—Irinotecan—breast cancer	0.00324	0.00348	CcSEcCtD
Guaifenesin—Headache—Mitoxantrone—breast cancer	0.00324	0.00348	CcSEcCtD
Guaifenesin—Vomiting—Gemcitabine—breast cancer	0.0032	0.00344	CcSEcCtD
Guaifenesin—Rash—Gemcitabine—breast cancer	0.00318	0.00342	CcSEcCtD
Guaifenesin—Dermatitis—Gemcitabine—breast cancer	0.00317	0.00341	CcSEcCtD
Guaifenesin—Headache—Gemcitabine—breast cancer	0.00316	0.00339	CcSEcCtD
Guaifenesin—Vomiting—Fluorouracil—breast cancer	0.00315	0.00339	CcSEcCtD
Guaifenesin—Chlorphenesin—CYP3A4—breast cancer	0.00313	0.0449	CrCbGaD
Guaifenesin—Rash—Fluorouracil—breast cancer	0.00312	0.00336	CcSEcCtD
Guaifenesin—Dermatitis—Fluorouracil—breast cancer	0.00312	0.00335	CcSEcCtD
Guaifenesin—Headache—Fluorouracil—breast cancer	0.0031	0.00334	CcSEcCtD
Guaifenesin—Nausea—Mitoxantrone—breast cancer	0.00307	0.0033	CcSEcCtD
Guaifenesin—Nausea—Irinotecan—breast cancer	0.00307	0.0033	CcSEcCtD
Guaifenesin—Chlorphenesin—PTGS2—breast cancer	0.00306	0.044	CrCbGaD
Guaifenesin—Alprenolol—CYP2D6—breast cancer	0.00306	0.0439	CrCbGaD
Guaifenesin—Nausea—Gemcitabine—breast cancer	0.00299	0.00322	CcSEcCtD
Guaifenesin—Nausea—Fluorouracil—breast cancer	0.00294	0.00316	CcSEcCtD
Guaifenesin—Dizziness—Paclitaxel—breast cancer	0.00279	0.003	CcSEcCtD
Guaifenesin—Carvedilol—PTGS1—breast cancer	0.00277	0.0398	CrCbGaD
Guaifenesin—Urticaria—Capecitabine—breast cancer	0.00275	0.00296	CcSEcCtD
Guaifenesin—Vomiting—Paclitaxel—breast cancer	0.00268	0.00288	CcSEcCtD
Guaifenesin—Rash—Paclitaxel—breast cancer	0.00266	0.00286	CcSEcCtD
Guaifenesin—Dermatitis—Paclitaxel—breast cancer	0.00266	0.00286	CcSEcCtD
Guaifenesin—Discomfort—Methotrexate—breast cancer	0.00266	0.00286	CcSEcCtD
Guaifenesin—Headache—Paclitaxel—breast cancer	0.00264	0.00284	CcSEcCtD
Guaifenesin—Pindolol—CYP2D6—breast cancer	0.00263	0.0377	CrCbGaD
Guaifenesin—Carvedilol—CYP1A1—breast cancer	0.00254	0.0364	CrCbGaD
Guaifenesin—Nausea—Paclitaxel—breast cancer	0.00251	0.00269	CcSEcCtD
Guaifenesin—Discomfort—Epirubicin—breast cancer	0.00249	0.00267	CcSEcCtD
Guaifenesin—Dizziness—Docetaxel—breast cancer	0.00236	0.00254	CcSEcCtD
Guaifenesin—Discomfort—Doxorubicin—breast cancer	0.0023	0.00247	CcSEcCtD
Guaifenesin—Dizziness—Capecitabine—breast cancer	0.00229	0.00246	CcSEcCtD
Guaifenesin—Vomiting—Docetaxel—breast cancer	0.00227	0.00244	CcSEcCtD
Guaifenesin—Rash—Docetaxel—breast cancer	0.00225	0.00242	CcSEcCtD
Guaifenesin—Dermatitis—Docetaxel—breast cancer	0.00225	0.00242	CcSEcCtD
Guaifenesin—Headache—Docetaxel—breast cancer	0.00224	0.00241	CcSEcCtD
Guaifenesin—Vomiting—Capecitabine—breast cancer	0.0022	0.00237	CcSEcCtD
Guaifenesin—Rash—Capecitabine—breast cancer	0.00218	0.00235	CcSEcCtD
Guaifenesin—Dermatitis—Capecitabine—breast cancer	0.00218	0.00234	CcSEcCtD
Guaifenesin—Headache—Capecitabine—breast cancer	0.00217	0.00233	CcSEcCtD
Guaifenesin—Nausea—Docetaxel—breast cancer	0.00212	0.00228	CcSEcCtD
Guaifenesin—Nausea—Capecitabine—breast cancer	0.00206	0.00221	CcSEcCtD
Guaifenesin—Urticaria—Methotrexate—breast cancer	0.00205	0.0022	CcSEcCtD
Guaifenesin—Propranolol—CYP1A1—breast cancer	0.00193	0.0277	CrCbGaD
Guaifenesin—Urticaria—Epirubicin—breast cancer	0.00192	0.00206	CcSEcCtD
Guaifenesin—Carvedilol—CYP2D6—breast cancer	0.00189	0.0271	CrCbGaD
Guaifenesin—Urticaria—Doxorubicin—breast cancer	0.00177	0.00191	CcSEcCtD
Guaifenesin—Dizziness—Methotrexate—breast cancer	0.0017	0.00183	CcSEcCtD
Guaifenesin—Vomiting—Methotrexate—breast cancer	0.00164	0.00176	CcSEcCtD
Guaifenesin—Rash—Methotrexate—breast cancer	0.00163	0.00175	CcSEcCtD
Guaifenesin—Dermatitis—Methotrexate—breast cancer	0.00162	0.00175	CcSEcCtD
Guaifenesin—Carvedilol—CYP3A4—breast cancer	0.00162	0.0232	CrCbGaD
Guaifenesin—Headache—Methotrexate—breast cancer	0.00161	0.00174	CcSEcCtD
Guaifenesin—Dizziness—Epirubicin—breast cancer	0.0016	0.00171	CcSEcCtD
Guaifenesin—Vomiting—Epirubicin—breast cancer	0.00153	0.00165	CcSEcCtD
Guaifenesin—Nausea—Methotrexate—breast cancer	0.00153	0.00165	CcSEcCtD
Guaifenesin—Rash—Epirubicin—breast cancer	0.00152	0.00163	CcSEcCtD
Guaifenesin—Dermatitis—Epirubicin—breast cancer	0.00152	0.00163	CcSEcCtD
Guaifenesin—Headache—Epirubicin—breast cancer	0.00151	0.00162	CcSEcCtD
Guaifenesin—Dizziness—Doxorubicin—breast cancer	0.00148	0.00159	CcSEcCtD
Guaifenesin—Propranolol—CYP2D6—breast cancer	0.00143	0.0206	CrCbGaD
Guaifenesin—Nausea—Epirubicin—breast cancer	0.00143	0.00154	CcSEcCtD
Guaifenesin—Vomiting—Doxorubicin—breast cancer	0.00142	0.00153	CcSEcCtD
Guaifenesin—Rash—Doxorubicin—breast cancer	0.00141	0.00151	CcSEcCtD
Guaifenesin—Dermatitis—Doxorubicin—breast cancer	0.00141	0.00151	CcSEcCtD
Guaifenesin—Headache—Doxorubicin—breast cancer	0.0014	0.0015	CcSEcCtD
Guaifenesin—Carvedilol—ABCB1—breast cancer	0.00135	0.0193	CrCbGaD
Guaifenesin—Nausea—Doxorubicin—breast cancer	0.00133	0.00143	CcSEcCtD
Guaifenesin—Propranolol—CYP3A4—breast cancer	0.00123	0.0177	CrCbGaD
Guaifenesin—Propranolol—ABCB1—breast cancer	0.00102	0.0147	CrCbGaD
